Abstract
Summary
OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility. The prevalence rate of OA is extremely high, affecting more than 250 million people worldwide. With increases in the aging and obese populations, the prevalence of OA is predicted to increase to 67 million by 2030. Hence, an effective and safe OA treatment is urgently required.
Stem cells are the body's raw materials — cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No other cell in the body has the natural ability to generate new cell types.
The global Stem Cell Therapy for Osteoarthritis market is projected to grow from US$ 42 million in 2024 to US$ 202 million by 2030, at a Compound Annual Growth Rate (CAGR) of 29.9% during the forecast period.
The key players of Stem Cell Therapy for Osteoarthritis include Medipost, Theracell Advanced Biotechnology, Nature Cell and Stempeutics. The top 2 manufacturers hold approximately 84% of the global market share.
In terms of product type, Fat Cell is the largest segment, with a share of 94%. And in terms of application, Primary Osteoarthritis has a share about 91 percent.
Report Includes
This report presents an overview of global market for Stem Cell Therapy for Osteoarthritis market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Stem Cell Therapy for Osteoarthritis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Stem Cell Therapy for Osteoarthritis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Stem Cell Therapy for Osteoarthritis revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Stem Cell Therapy for Osteoarthritis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Stem Cell Therapy for Osteoarthritis revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Medipost, Theracell Advanced Biotechnology, Nature Cell, Stempeutics, Regeneus, Xintela AB, Cells for Cells, CellTex Therapeutics, UCI Health, Magellan, etc.
Market Segmentation
By Company
Medipost
Theracell Advanced Biotechnology
Nature Cell
Stempeutics
Regeneus
Xintela AB
Cells for Cells
CellTex Therapeutics
UCI Health
Magellan
AbelZeta Pharma
Segment by Type
Fat Cell
Bone Marrow Cell
Others
Segment by Application
Primary Osteoarthritis
Secondary Osteoarthritis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of South America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Stem Cell Therapy for Osteoarthritis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stem Cell Therapy for Osteoarthritis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stem Cell Therapy for Osteoarthritis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fat Cell
1.2.3 Bone Marrow Cell
1.2.4 Others
1.3 Market by Application
1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Share by Application: 2019 VS 2023 VS 2030
1.3.2 Primary Osteoarthritis
1.3.3 Secondary Osteoarthritis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy for Osteoarthritis Market Perspective (2019-2030)
2.2 Global Stem Cell Therapy for Osteoarthritis Growth Trends by Region
2.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Stem Cell Therapy for Osteoarthritis Historic Market Size by Region (2019-2024)
2.2.3 Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Region (2025-2030)
2.3 Stem Cell Therapy for Osteoarthritis Market Dynamics
2.3.1 Stem Cell Therapy for Osteoarthritis Industry Trends
2.3.2 Stem Cell Therapy for Osteoarthritis Market Drivers
2.3.3 Stem Cell Therapy for Osteoarthritis Market Challenges
2.3.4 Stem Cell Therapy for Osteoarthritis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Stem Cell Therapy for Osteoarthritis by Players
3.1.1 Global Stem Cell Therapy for Osteoarthritis Revenue by Players (2019-2024)
3.1.2 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Players (2019-2024)
3.2 Global Stem Cell Therapy for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Stem Cell Therapy for Osteoarthritis, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio
3.4.1 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Osteoarthritis Revenue in 2023
3.5 Global Key Players of Stem Cell Therapy for Osteoarthritis Head office and Area Served
3.6 Global Key Players of Stem Cell Therapy for Osteoarthritis, Product and Application
3.7 Global Key Players of Stem Cell Therapy for Osteoarthritis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Therapy for Osteoarthritis Breakdown Data by Type
4.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Type (2019-2024)
4.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2025-2030)
5 Stem Cell Therapy for Osteoarthritis Breakdown Data by Application
5.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Application (2019-2024)
5.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
6.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Type
6.2.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2019-2024)
6.2.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2025-2030)
6.2.3 North America Stem Cell Therapy for Osteoarthritis Market Share by Type (2019-2030)
6.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Application
6.3.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2019-2024)
6.3.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2025-2030)
6.3.3 North America Stem Cell Therapy for Osteoarthritis Market Share by Application (2019-2030)
6.4 North America Stem Cell Therapy for Osteoarthritis Market Size by Country
6.4.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024)
6.4.3 North America Stem Cell Therapy for Osteoarthritis Market Share by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
7.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type
7.2.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2019-2024)
7.2.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2025-2030)
7.2.3 Europe Stem Cell Therapy for Osteoarthritis Market Share by Type (2019-2030)
7.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application
7.3.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2019-2024)
7.3.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2025-2030)
7.3.3 Europe Stem Cell Therapy for Osteoarthritis Market Share by Application (2019-2030)
7.4 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country
7.4.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024)
7.4.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K
7.4.7 Italy
7.4.8 Russia
7.4.9 Nordic Countries
8 China
8.1 China Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
8.2 China Stem Cell Therapy for Osteoarthritis Market Size by Type
8.2.1 China Stem Cell Therapy for Osteoarthritis Market Size by Type (2019-2024)
8.2.2 China Stem Cell Therapy for Osteoarthritis Market Size by Type (2025-2030)
8.2.3 China Stem Cell Therapy for Osteoarthritis Market Share by Type (2019-2030)
8.3 China Stem Cell Therapy for Osteoarthritis Market Size by Application
8.3.1 China Stem Cell Therapy for Osteoarthritis Market Size by Application (2019-2024)
8.3.2 China Stem Cell Therapy for Osteoarthritis Market Size by Application (2025-2030)
8.3.3 China Stem Cell Therapy for Osteoarthritis Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
9.2 Asia Stem Cell Therapy for Osteoarthritis Market Size by Type
9.2.1 Asia Stem Cell Therapy for Osteoarthritis Market Size by Type (2019-2024)
9.2.2 Asia Stem Cell Therapy for Osteoarthritis Market Size by Type (2025-2030)
9.2.3 Asia Stem Cell Therapy for Osteoarthritis Market Share by Type (2019-2030)
9.3 Asia Stem Cell Therapy for Osteoarthritis Market Size by Application
9.3.1 Asia Stem Cell Therapy for Osteoarthritis Market Size by Application (2019-2024)
9.3.2 Asia Stem Cell Therapy for Osteoarthritis Market Size by Application (2025-2030)
9.3.3 Asia Stem Cell Therapy for Osteoarthritis Market Share by Application (2019-2030)
9.4 Asia Stem Cell Therapy for Osteoarthritis Market Size by Region
9.4.1 Asia Stem Cell Therapy for Osteoarthritis Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Stem Cell Therapy for Osteoarthritis Market Size by Region (2019-2024)
9.4.3 Asia Stem Cell Therapy for Osteoarthritis Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type
10.2.1 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application
10.3.1 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country
10.4.1 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Medipost
11.1.1 Medipost Company Details
11.1.2 Medipost Business Overview
11.1.3 Medipost Stem Cell Therapy for Osteoarthritis Introduction
11.1.4 Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.1.5 Medipost Recent Development
11.2 Theracell Advanced Biotechnology
11.2.1 Theracell Advanced Biotechnology Company Details
11.2.2 Theracell Advanced Biotechnology Business Overview
11.2.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Introduction
11.2.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.2.5 Theracell Advanced Biotechnology Recent Development
11.3 Nature Cell
11.3.1 Nature Cell Company Details
11.3.2 Nature Cell Business Overview
11.3.3 Nature Cell Stem Cell Therapy for Osteoarthritis Introduction
11.3.4 Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.3.5 Nature Cell Recent Development
11.4 Stempeutics
11.4.1 Stempeutics Company Details
11.4.2 Stempeutics Business Overview
11.4.3 Stempeutics Stem Cell Therapy for Osteoarthritis Introduction
11.4.4 Stempeutics Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.4.5 Stempeutics Recent Development
11.5 Regeneus
11.5.1 Regeneus Company Details
11.5.2 Regeneus Business Overview
11.5.3 Regeneus Stem Cell Therapy for Osteoarthritis Introduction
11.5.4 Regeneus Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.5.5 Regeneus Recent Development
11.6 Xintela AB
11.6.1 Xintela AB Company Details
11.6.2 Xintela AB Business Overview
11.6.3 Xintela AB Stem Cell Therapy for Osteoarthritis Introduction
11.6.4 Xintela AB Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.6.5 Xintela AB Recent Development
11.7 Cells for Cells
11.7.1 Cells for Cells Company Details
11.7.2 Cells for Cells Business Overview
11.7.3 Cells for Cells Stem Cell Therapy for Osteoarthritis Introduction
11.7.4 Cells for Cells Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.7.5 Cells for Cells Recent Development
11.8 CellTex Therapeutics
11.8.1 CellTex Therapeutics Company Details
11.8.2 CellTex Therapeutics Business Overview
11.8.3 CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Introduction
11.8.4 CellTex Therapeutics Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.8.5 CellTex Therapeutics Recent Development
11.9 UCI Health
11.9.1 UCI Health Company Details
11.9.2 UCI Health Business Overview
11.9.3 UCI Health Stem Cell Therapy for Osteoarthritis Introduction
11.9.4 UCI Health Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.9.5 UCI Health Recent Development
11.10 Magellan
11.10.1 Magellan Company Details
11.10.2 Magellan Business Overview
11.10.3 Magellan Stem Cell Therapy for Osteoarthritis Introduction
11.10.4 Magellan Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.10.5 Magellan Recent Development
11.11 AbelZeta Pharma
11.11.1 AbelZeta Pharma Company Details
11.11.2 AbelZeta Pharma Business Overview
11.11.3 AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Introduction
11.11.4 AbelZeta Pharma Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.11.5 AbelZeta Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer